Page last updated: 2024-10-17

fosmidomycin and Typhus, Epidemic Louse-Borne

fosmidomycin has been researched along with Typhus, Epidemic Louse-Borne in 1 studies

fosmidomycin: from Streptomyces lavendulae; RN given refers to parent cpd; structure in second source
fosmidomycin : Propylphosphonic acid in which one of the hydrogens at position 3 is substituted by a formyl(hydroxy)amino group. An antibiotic obtained from Streptomyces lavendulae, it specifically inhibits DXP reductoisomerase (EC 1.1.1.267), a key enzyme in the non-mevalonate pathway of isoprenoid biosynthesis.

Typhus, Epidemic Louse-Borne: The classic form of typhus, caused by RICKETTSIA PROWAZEKII, which is transmitted from man to man by the louse Pediculus humanus corporis. This disease is characterized by the sudden onset of intense headache, malaise, and generalized myalgia followed by the formation of a macular skin eruption and vascular and neurologic disturbances.

Research Excerpts

ExcerptRelevanceReference
"Antibiotic fosmidomycin will know as inhibitor of the nonmevalonate pathway of isoprenoid biosynthesis and as possible antimalarial drug, was shown to possess a certain protective effect on mice experimentally infected with tularemia, tiphus or coli-septicemia."3.72[Effect of fosfidomycin on development of various infections in mice]. ( Bakhteeva, IV; Biketov, SF; Biniukov, VI; Borzenkov, VN; OstrovskiÄ­, DN; Potapov, VD; Titareva, GM; Wiesner, J, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Potapov, VD1
Bakhteeva, IV1
Borzenkov, VN1
Titareva, GM1
Wiesner, J1
Biniukov, VI1
OstrovskiÄ­, DN1
Biketov, SF1

Other Studies

1 other study available for fosmidomycin and Typhus, Epidemic Louse-Borne

ArticleYear
[Effect of fosfidomycin on development of various infections in mice].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2003, Volume: 48, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Escherichia coli Infections; Fosfomycin; Mice;

2003